Biofrontera stock jumps 13.83% intraday amid volatile trading and lack of fundamental news.

Biofrontera surged 13.83% intraday amid heightened volatility and increased trading volume, despite a lack of company-specific or sector-related news. The stock broke above its 30-day moving average and approached its 52-week high, with no clear fundamental catalyst to explain the move. Analysts attribute the rally to speculative or algorithmic trading activity, as the broader pharmaceutical sector remained flat. The absence of thematic support and bearish technical indicators suggest the upswing may be short-lived. Traders are closely watching key resistance levels for signs of sustained momentum.